Medicine

Integrating liver endpoints in scientific trials of cardio and also renal condition

.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires introduction of people with MASLD and also size of liver results in cardio-- renal-- metabolic tests, when information suggest mechanistically probable benefits and also scientific safety-- and summarizes factors to consider for test design and also regulatory approval.